These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24285369)

  • 41. Glycogen synthase kinase-3β inhibition improved survivability of mice infected with Burkholderia pseudomallei.
    Tay TF; Maheran M; Too SL; Hasidah MS; Ismail G; Embi N
    Trop Biomed; 2012 Dec; 29(4):551-67. PubMed ID: 23202600
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Survey of innate immune responses to Burkholderia pseudomallei in human blood identifies a central role for lipopolysaccharide.
    Chantratita N; Tandhavanant S; Myers ND; Seal S; Arayawichanont A; Kliangsa-Ad A; Hittle LE; Ernst RK; Emond MJ; Wurfel MM; Day NP; Peacock SJ; West TE
    PLoS One; 2013; 8(11):e81617. PubMed ID: 24303060
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immune responses in beta-thalassaemia: heme oxygenase 1 reduces cytokine production and bactericidal activity of human leucocytes.
    Nithichanon A; Tussakhon I; Samer W; Kewcharoenwong C; Ato M; Bancroft GJ; Lertmemongkolchai G
    Sci Rep; 2020 Jun; 10(1):10297. PubMed ID: 32581238
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Urokinase receptor is necessary for bacterial defense against pneumonia-derived septic melioidosis by facilitating phagocytosis.
    Wiersinga WJ; Kager LM; Hovius JW; van der Windt GJ; de Vos AF; Meijers JC; Roelofs JJ; Dondorp A; Levi M; Day NP; Peacock SJ; van der Poll T
    J Immunol; 2010 Mar; 184(6):3079-86. PubMed ID: 20142364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlates of immune protection following cutaneous immunization with an attenuated Burkholderia pseudomallei vaccine.
    Silva EB; Goodyear A; Sutherland MD; Podnecky NL; Gonzalez-Juarrero M; Schweizer HP; Dow SW
    Infect Immun; 2013 Dec; 81(12):4626-34. PubMed ID: 24101688
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A critical role for neutrophils in resistance to experimental infection with Burkholderia pseudomallei.
    Easton A; Haque A; Chu K; Lukaszewski R; Bancroft GJ
    J Infect Dis; 2007 Jan; 195(1):99-107. PubMed ID: 17152013
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Caspase-6 mediates resistance against Burkholderia pseudomallei infection and influences the expression of detrimental cytokines.
    Bartel A; Göhler A; Hopf V; Breitbach K
    PLoS One; 2017; 12(7):e0180203. PubMed ID: 28686630
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Medication of the month. Glucovance in type 2 diabetes, a fixed combination of metformin-glibenclamide for the treatment of a bipolar metabolic disease].
    Scheen AJ
    Rev Med Liege; 2003 Jun; 58(6):448-52. PubMed ID: 12945247
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potential of repurposing chloroquine as an adjunct therapy for melioidosis based on a murine model of Burkholderia pseudomallei infection.
    Ganesan N; Embi N; Hasidah MS
    Trop Biomed; 2020 Jun; 37(2):303-317. PubMed ID: 33612800
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Feline polymorphonuclear neutrophils produce pro-inflammatory cytokines following exposure to Microsporum canis.
    Cambier L; Mathy A; Baldo A; Bagut ET; Tabart J; Antoine N; Mignon B
    Vet Microbiol; 2013 Mar; 162(2-4):800-805. PubMed ID: 23141297
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of the early host immune response to two widely diverse virulent strains of Burkholderia pseudomallei that cause acute or chronic infections in BALB/c mice.
    Amemiya K; Dankmeyer JL; Fetterer DP; Worsham PL; Welkos SL; Cote CK
    Microb Pathog; 2015 Sep; 86():53-63. PubMed ID: 26162294
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enemies or weapons in hands: investigational anti-diabetic drug glibenclamide and cancer risk.
    Gao R; Yang T; Xu W
    Expert Opin Investig Drugs; 2017 Jul; 26(7):853-864. PubMed ID: 28541801
    [TBL] [Abstract][Full Text] [Related]  

  • 53. T-Cell Responses Are Associated with Survival in Acute Melioidosis Patients.
    Jenjaroen K; Chumseng S; Sumonwiriya M; Ariyaprasert P; Chantratita N; Sunyakumthorn P; Hongsuwan M; Wuthiekanun V; Fletcher HA; Teparrukkul P; Limmathurotsakul D; Day NP; Dunachie SJ
    PLoS Negl Trop Dis; 2015 Oct; 9(10):e0004152. PubMed ID: 26495852
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immune response to Burkholderia pseudomallei.
    Panomket P
    J Med Assoc Thai; 2011 Nov; 94(11):1410-7. PubMed ID: 22256484
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of a murine model of melioidosis: comparison of different strains of mice.
    Hoppe I; Brenneke B; Rohde M; Kreft A; Häussler S; Reganzerowski A; Steinmetz I
    Infect Immun; 1999 Jun; 67(6):2891-900. PubMed ID: 10338496
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Seroprevalence of melioidosis in diabetic patients in Taiwan.
    Chen WT; Chen YS; Chye SM; Wu TR; Hong WG; Lin YN; Bair HT; Yang SC; Chen YL
    J Microbiol Immunol Infect; 2005 Aug; 38(4):267-70. PubMed ID: 16118674
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A case report of Tubo-ovarian abscess caused by Burkholderia pseudomallei.
    Nernsai P; Sophonsritsuk A; Lertvikool S; Jinawath A; Chitasombat MN
    BMC Infect Dis; 2018 Feb; 18(1):73. PubMed ID: 29422033
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rapid DNA vaccination against Burkholderia pseudomallei flagellin by tattoo or intranasal application.
    Lankelma JM; Wagemakers A; Birnie E; Haak BW; Trentelman JJA; Weehuizen TAF; Ersöz J; Roelofs JJTH; Hovius JW; Wiersinga WJ; Bins AD
    Virulence; 2017 Nov; 8(8):1683-1694. PubMed ID: 28323523
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endogenous interleukin-18 improves the early antimicrobial host response in severe melioidosis.
    Wiersinga WJ; Wieland CW; van der Windt GJ; de Boer A; Florquin S; Dondorp A; Day NP; Peacock SJ; van der Poll T
    Infect Immun; 2007 Aug; 75(8):3739-46. PubMed ID: 17517876
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Protective Role of Glibenclamide in Inflammation-Associated Injury.
    Zhang G; Lin X; Zhang S; Xiu H; Pan C; Cui W
    Mediators Inflamm; 2017; 2017():3578702. PubMed ID: 28740332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.